vs
FLEXSTEEL INDUSTRIES INC（FLXS）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是FLEXSTEEL INDUSTRIES INC的1.1倍（$127.1M vs $115.1M），再鼎医药同比增速更快（17.1% vs 1.0%），过去两年再鼎医药的营收复合增速更高（20.8% vs 1.9%）
Flexsteel Industries Inc是一家总部位于美国的家具制造商，设计、生产并销售各类软垫住宅家具、商用家具及酒店家具，主要面向北美市场运营，通过广泛的分销网络服务终端消费者、零售合作伙伴及企业客户。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
FLXS vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.1倍
$115.1M
营收增速更快
ZLAB
高出16.1%
1.0%
两年增速更快
ZLAB
近两年复合增速
1.9%
损益表 — Q1 FY2027 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $115.1M | $127.1M |
| 净利润 | $20.4M | — |
| 毛利率 | 22.6% | 51.0% |
| 营业利润率 | — | -54.6% |
| 净利率 | 17.7% | — |
| 营收同比 | 1.0% | 17.1% |
| 净利润同比 | 116.0% | — |
| 每股收益（稀释后） | $1.14 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FLXSZLAB
| Q3 26 | $115.1M | — | ||
| Q4 25 | $118.2M | $127.1M | ||
| Q3 25 | $110.4M | $115.4M | ||
| Q2 25 | $114.6M | $109.1M | ||
| Q1 25 | $114.0M | $105.7M | ||
| Q4 24 | $108.5M | $108.5M | ||
| Q3 24 | $104.0M | $101.8M | ||
| Q2 24 | $110.8M | $100.1M |
净利润FLXSZLAB
| Q3 26 | $20.4M | — | ||
| Q4 25 | $6.6M | — | ||
| Q3 25 | $7.3M | $-36.0M | ||
| Q2 25 | $10.7M | $-40.7M | ||
| Q1 25 | $-3.7M | $-48.4M | ||
| Q4 24 | $9.1M | — | ||
| Q3 24 | $4.1M | $-41.7M | ||
| Q2 24 | $4.9M | $-80.3M |
毛利率FLXSZLAB
| Q3 26 | 22.6% | — | ||
| Q4 25 | 22.7% | 51.0% | ||
| Q3 25 | 23.5% | 59.5% | ||
| Q2 25 | 23.9% | 60.6% | ||
| Q1 25 | 22.2% | 63.6% | ||
| Q4 24 | 21.0% | 61.5% | ||
| Q3 24 | 21.5% | 64.1% | ||
| Q2 24 | 21.3% | 64.9% |
营业利润率FLXSZLAB
| Q3 26 | — | — | ||
| Q4 25 | 7.6% | -54.6% | ||
| Q3 25 | 8.1% | -42.3% | ||
| Q2 25 | 12.2% | -50.3% | ||
| Q1 25 | -4.4% | -53.3% | ||
| Q4 24 | 10.7% | -62.6% | ||
| Q3 24 | 5.8% | -66.6% | ||
| Q2 24 | 6.9% | -76.0% |
净利率FLXSZLAB
| Q3 26 | 17.7% | — | ||
| Q4 25 | 5.6% | — | ||
| Q3 25 | 6.6% | -31.2% | ||
| Q2 25 | 9.3% | -37.3% | ||
| Q1 25 | -3.3% | -45.8% | ||
| Q4 24 | 8.3% | — | ||
| Q3 24 | 4.0% | -40.9% | ||
| Q2 24 | 4.4% | -80.2% |
每股收益（稀释后）FLXSZLAB
| Q3 26 | $1.14 | — | ||
| Q4 25 | $1.18 | $-0.05 | ||
| Q3 25 | $1.31 | $-0.03 | ||
| Q2 25 | $1.90 | $-0.04 | ||
| Q1 25 | $-0.71 | $-0.04 | ||
| Q4 24 | $1.62 | $-0.09 | ||
| Q3 24 | $0.74 | $-0.04 | ||
| Q2 24 | $0.87 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $57.3M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $185.3M | $715.5M |
| 总资产 | $290.2M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FLXSZLAB
| Q3 26 | $57.3M | — | ||
| Q4 25 | $36.8M | $689.6M | ||
| Q3 25 | $38.6M | $717.2M | ||
| Q2 25 | $40.0M | $732.2M | ||
| Q1 25 | $22.6M | $757.3M | ||
| Q4 24 | $11.8M | $779.7M | ||
| Q3 24 | $5.7M | $616.1M | ||
| Q2 24 | $4.8M | $630.0M |
股东权益FLXSZLAB
| Q3 26 | $185.3M | — | ||
| Q4 25 | $178.9M | $715.5M | ||
| Q3 25 | $172.2M | $759.9M | ||
| Q2 25 | $167.9M | $791.7M | ||
| Q1 25 | $158.1M | $810.8M | ||
| Q4 24 | $161.9M | $840.9M | ||
| Q3 24 | $154.7M | $667.7M | ||
| Q2 24 | $150.4M | $704.2M |
总资产FLXSZLAB
| Q3 26 | $290.2M | — | ||
| Q4 25 | $290.2M | $1.2B | ||
| Q3 25 | $281.5M | $1.2B | ||
| Q2 25 | $282.5M | $1.2B | ||
| Q1 25 | $266.1M | $1.2B | ||
| Q4 24 | $271.5M | $1.2B | ||
| Q3 24 | $268.7M | $985.3M | ||
| Q2 24 | $274.5M | $987.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.2M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-26.7M |
| 自由现金流率自由现金流/营收 | — | -21.0% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | 1.33× | — |
| 过去12个月自由现金流最近4个季度 | — | $-158.9M |
8季度趋势，按日历期对齐
经营现金流FLXSZLAB
| Q3 26 | $27.2M | — | ||
| Q4 25 | $1.0M | $-26.0M | ||
| Q3 25 | $4.1M | $-32.0M | ||
| Q2 25 | $15.6M | $-31.0M | ||
| Q1 25 | $12.3M | $-61.7M | ||
| Q4 24 | $6.7M | $-55.8M | ||
| Q3 24 | $2.4M | $-26.8M | ||
| Q2 24 | $7.5M | $-42.2M |
自由现金流FLXSZLAB
| Q3 26 | — | — | ||
| Q4 25 | $-735.0K | $-26.7M | ||
| Q3 25 | $2.8M | $-35.0M | ||
| Q2 25 | $15.1M | $-33.9M | ||
| Q1 25 | $10.9M | $-63.2M | ||
| Q4 24 | $5.8M | $-58.4M | ||
| Q3 24 | $2.0M | $-28.2M | ||
| Q2 24 | $7.1M | $-42.9M |
自由现金流率FLXSZLAB
| Q3 26 | — | — | ||
| Q4 25 | -0.6% | -21.0% | ||
| Q3 25 | 2.5% | -30.4% | ||
| Q2 25 | 13.1% | -31.1% | ||
| Q1 25 | 9.6% | -59.9% | ||
| Q4 24 | 5.3% | -53.8% | ||
| Q3 24 | 1.9% | -27.7% | ||
| Q2 24 | 6.4% | -42.9% |
资本支出强度FLXSZLAB
| Q3 26 | — | — | ||
| Q4 25 | 1.5% | 0.5% | ||
| Q3 25 | 1.2% | 2.6% | ||
| Q2 25 | 0.5% | 2.6% | ||
| Q1 25 | 1.2% | 1.5% | ||
| Q4 24 | 0.8% | 2.4% | ||
| Q3 24 | 0.4% | 1.3% | ||
| Q2 24 | 0.4% | 0.7% |
现金转化率FLXSZLAB
| Q3 26 | 1.33× | — | ||
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.56× | — | ||
| Q2 25 | 1.46× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 0.58× | — | ||
| Q2 24 | 1.53× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FLXS
暂无分部数据
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
